Share this article Share this article NEW YORK, April 20, 2021 /PRNewswire/ -- Mirimus, Inc., a leader in conducting high-volume, high-quality PCR testing, today announced that since November 2020 it has worked with St. John's University, a coeducational Catholic and Vincentian university in New York, to conduct rigorous COVID-19 surveillance testing of student athletes using its pioneering SalivaClear COVID-19 pooled saliva testing platform. The SalivaClear platform consists of three key elements – saliva-based sampling, pooled testing and gold-standard PCR molecular diagnostics – that, when combined, enable frequent, high-quality, high-throughput, low-cost detection of SARS-CoV-2, the virus that causes COVID-19. Mirimus SalivaClear COVID-19 Pool Testing St. John's initiated its COVID-19 surveillance program on June 26, 2020 and tests all 300+ student-athletes participating in the university's athletic program, which includes 17 sports, as well as coaches and staff, at least twice per week. Since St. John's program with Mirimus began, more than 8,000 saliva-based tests comprising more than 330 pools have been performed. The resulting data has helped the university's sports health administrators guide and adjust teams' response to the COVID-19 outbreak and has been an essential component in enabling the St. John's athletic teams to remain safe and active.